Press Releases
-
Jan31
Cancer Genetics, Inc. Announces Closing of Public Offering of Common Stock
RUTHERFORD, N.J., Jan. 31, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling
-
Jan28
Cancer Genetics, Inc. Announces Pricing of $3.5 Million Public Offering of Common Stock
RUTHERFORD, N.J., Jan. 28, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling
-
Jan28
Cancer Genetics, Inc. Announces Proposed Public Offering of Common Stock
RUTHERFORD, N.J., Jan. 28, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling
-
Jan16
Cancer Genetics Issues Letter to Shareholders
RUTHERFORD, N.J., Jan. 16, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling
-
Jan14
Cancer Genetics, Inc. Announces Closing of Public Offering of Common Stock
RUTHERFORD, N.J., Jan. 14, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling
-
Jan9
Cancer Genetics, Inc. Announces Pricing of Public Offering of Common Stock
RUTHERFORD, N.J., Jan. 09, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling
-
Jan9
Cancer Genetics, Inc. Announces Proposed Public Offering of Common Stock
RUTHERFORD, N.J., Jan. 09, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling
-
Jan9
Cancer Genetics Strengthens Management Team with Appointment of William Finger as Executive Vice President, Precision Medicine and Pharma Services
Executive appointment underscores continued execution of new corporate strategy of expanding Biopharma and Discovery
-
Dec17
Cancer Genetics Terminates Proposed Merger with NovellusDx
RUTHERFORD, N.J., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling
-
Nov19
Cancer Genetics Reports Third Quarter 2018 Financial Results and Provides Strategic Business Updates
RUTHERFORD, N.J., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling
